An unexpected result has been put forward by Chen et al. [40], who studied the relationship between PTEN dose and tumor progression in mouse models of prostate specific loss of PTEN: complete acute loss of PTEN promoted a strong senescence response opposing tumor progression. This evidence concerns the gene PTEN and neoplasm.